Analysts/Institutional Investor Meet/Con. Call Updates

Date: 20th August, 2026 To, To, National Stock Exchange of India Limited BSE Limited (“BSE”), (“NSE”), The Listing Department Corporate Relationship Department, Exchange Plaza, 5th Floor, 2nd Floor, New Trading Ring, Plot No. C/1, G Block, Bandra-Kurla P.J. Towers, Dalal Street, Complex Bandra (East), Mumbai – 400 001. Mumbai – 400 051. NSE Symbol: STALLION BSE Scrip Code: 544342 ISIN: INE0RYC01010 ISIN: INE0RYC01010 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Transcript of the Investor Conference. Dear Sir/Ma’am, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Investor Conference held on Monday, 17th August, 2026, at 04.00 P.M. IST with regard to the business and financial performance of the Company for the quarter ended 30th June, 2026. The transcript has also been uploaded on the Company’s website and can be accessed through the following link: https://stallionfluorochemicals.com/investors-information/earning-call/ You are requested to kindly note the same. Yours Faithfully, For Stallion India Fluorochemicals Limited Govind Rao Company Secretary & Compliance Officer Mem. No. A47094 Stallion India Fluorochemicals Limited Q1 FY27 Earnings Conference Call Event Date / Time: 17/08/2026, 04:00 PM Moderator: Ladies and gentlemen, good evening and welcome to Q1 FY27 earnings call of Stallion India Fluorochemicals Limited hosted by ConfideLeap Partners. As a reminder, all participants' lines will remain in listen-only mode and there will be an opportunity for you to ask questions after the management's opening remark and presentation. Please note that this earnings conference call is being recorded. Before we begin, I would like to mention that certain statements made during this conference call may be forward-looking in nature. These statements are based on the current expectations, assumptions and estimates of the management and are subjected to various risks and uncertainties. The Actual results may differ materially from those expressed or implied due to several factors. The company undertakes no obligation to publicly update or revise any forward- looking statement. We represent the investor relations for Stallion India Fluorochemicals Limited and on behalf of Confideleap Partners I extend a warm welcome to all the investors, analysts and participants for joining the Q1 FY27 earnings con-call. We have with us Mr. Shehzad Rustamji who is the Managing Director and CEO of Stallion India Fluorochemicals Limited. Sir, you may now proceed. Shehzad Rustamji: Thank you. Good afternoon, everyone and a warm welcome to Stallion India Fluorochemicals Limited Q1 FY27 earnings conference call. We have started FY27 on a positive note. During the quarter our total revenue stood at 124.68 crores registering a growth of 12.78% year-on-year. EBITDA increased by 75.85% to 25.27 crore, while PAT grew by 79.15% to 18.57 crore. The stronger growth in EBITDA and PAT reflects the improvement we have seen in our profitability during the quarter. From an operational perspective the focus continues to be on strengthening the business and preparing the company for its next phase of growth. One of the key developments during the quarter was the completion of preparations for high purity helium processing plant at our Khalapur facility. The facility has an installed capacity of 1200 metric tons per annum and we expect commercial operations to begin in the coming quarter. We see good earning opportunities for high purity helium across areas such as semiconductors, electronics, healthcare, aerospace and defence. Our Mambattu facility in Andhra Pradesh is progressing as planned and we expect it to commence operation by end of the year. This facility will strengthen our presence in South India and add capacity for refrigerant de-bulking, blending and storage. More notably, it's an HFO blending plant. At the same time work on our 10,000 metric ton R32 manufacturing facility at Bhilwara is progressing well. We are targeting completion by end of December 26. This is an important project for us because it will take us further into manufacturing and reduce our dependence on external sourcing for this key refrigerant. The R32 facility is also an important part of our backward integration strategy. Over time we expect this to improve the supply reliability and contribute positively to our margins. Beyond these projects we continue to look at opportunities in HFO and other specialty gases. The objective is to gradually increase the contribution from higher value products while building on the customer base and distribution network that we already have. We remain confident of the opportunity ahead of us. Our focus over the next few quarters will be on executing these projects on time and gradually ramping up the new capacities. We continue to maintain our guidance of 30-35% revenue CAGR over the next three years. As the contribution from backward integration and higher value specialty gases increase, we also expect our EBITDA margins to improve by about 3 to 4% over the medium term. Overall, our focus remains on disciplined execution, expanding our product portfolio and building a stronger and more integrated business. With that I would like to thank all our investors and stakeholders for their continued support. I'm happy to take your questions. Moderator: Participants who would like to ask questions may raise their hands in the reactions tab. We have the first question from Ms. Disha. Ms. Disha, you may unmute and introduce yourself. Disha: Hello, am I audible sir? Shehzad Rustamji: Yes. Disha: Yes. Thank you so much for the opportunity. Couple of questions. First, sir, in our first quarter we've seen strong improvement in our gross margins and EBITDA margins both on a Q-o-Q basis and a Y-o-Y basis. I just wanted to understand how much of this has been driven by higher realization and how much of this has been driven by higher realization, how much of this has been driven by better product mix. And do you see these margins sustaining? Shehzad Rustamji: It is a combination of better product mix and also the earlier planning that we had in place. Basically, the continued strain on logistics and imports currently faced due to the Gulf crisis, it starts taking its toll on pricing and all other factors also. So, one has been a combination of better planning, better execution of earlier planned logistics that we had, and also a better product mix. A higher percentage of HFOs also in the sale. Disha: So, is it fair, sir, that these sorts of margins will be able to sustain? Shehzad Rustamji: Our margins would continuously improve, but I'm not particularly sure that the same results can be repeated ever continually. Like I said, part of it comes from the better planning that we had during the, you know, Gulf crisis time. So when everything has gone haywire, historically we've always had high stock-keeping. So that also comes into the beneficial mode for us when crisis happens. Disha: So out of this EBITDA, sir, how much of this has been because of the inventory gains or the stock that we had earlier? Shehzad Rustamji: It's a mix, 50:50. Disha: Okay, okay. Fair enough. And sir, this Khalapur plant I think is going to commercialize in the next quarter. What sort of contribution do you see from this plant for this year? Shehzad Rustamji: We should see about 12% contribution. Disha: And this has a PAT margin of around 17 to 18% right? Shehzad Rustamji: We've said 15% but yes it will be higher. Disha: Okay, okay. And sir what are the current R32 prices and what sort of increase have we seen in the helium prices? Shehzad Rustamji: R32 prices currently are a little on the downswing. It's not on a- it's not increasing. Basic correction that needed to come is coming. Disha: So what will be- what will be the price currently sir? She [Showing first 8,000 characters — download PDF for full document]